Lunit Inc. (KOSDAQ:328130)
South Korea · Delayed Price · Currency is KRW 14,980
+590 (4.10%)
Oct 29, 2026, 3:30 PM KST
Lunit Market Cap
Lunit has a market cap or net worth of 1.12 trillion as of October 28, 2026. It is the 11,290th most valuable company in the world and the 283rd biggest in South Korea. Its market cap has decreased by 6.39% in one year.
Market Cap
1.12T
Enterprise Value
1.03T
Revenue
91.82B
Global Rank
Country Rank
#283 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 21, 2022, Lunit's market cap has increased from 420.31B to 1.12T, an increase of 165.37%. That is a compound annual growth rate of 25.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 1.12T | -7.24% |
| Dec 30, 2025 | 1.20T | -34.88% |
| Dec 30, 2024 | 1.85T | -20.82% |
| Dec 28, 2023 | 2.33T | 540.04% |
| Dec 29, 2022 | 364.38B | -13.31% |
| Jul 21, 2022 | 420.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 63.44T |
| Celltrion | 43.36T |
| ALTEOGEN | 15.53T |
| Samsung Epis Holdings | 7.86T |
| L&C BIO Co.,LTD | 1.35T |
| Kolon TissueGene | 1.24T |
| Daewoong Pharmaceutical | 1.15T |
| DongKook Pharmaceutical | 1.08T |